Treatment with other immunosuppressants standard protocols:None
Sponsors
The Second Hospital of Shanxi Medical University
Conditions
IgA nephropathyMembranous Nephropathy
Unknown Phase
Obinutuzumab as Initial or Second-line Therapy in Patients with Primary Membranous Nephropathy: A multicenter prospective cohort study
Active, not recruitingChiCTR2400082133
Start: 2024-03-22Updated: 2024-03-25
Efficacy and safety of telitacicept in the treatment of primary IgA nephropathy: a prospective cohort study
Active, not recruitingChiCTR2400083991
Start: 2024-05-13Updated: 2024-05-13